Table 1.

Characteristics of the study sample.

CharacteristicsHip Defect Absent, n = 48Grade 1 Hip Defect Present, n = 66pGrade 2 Hip Defect Present, n = 80p
Age, yrs, mean (SD)64.1 (6.73)64.1 (6.84)0.9565.5 (7.70)0.01
BMI, kg/cm2, mean (SD)27.2 (3.99)28.2 (4.43)0.0227.5 (4.20)0.53
Hip pain
  Presence40%48%0.1446%0.81
    Men22%44%0.002
    Women62%53%0.2
    Interaction p value, p = 0.003
  Severity §, mean (SD)1.32 (3.14)2.10 (4.20)0.072.60 (5.11)0.03
Leg strength, kg, mean (SD)101 (53.0)99 (53.0)0.7198.0 (48.7)0.73
Steps per day, mean (SD)7970 (3526)7444 (3245)0.157127 (3507)0.04
Any BML5%20%0.00323%0.009
Presence of high cartilage signal42%60%0.00262%0.009
  Men40%70%< 0.001
  Women44%46%0.81
  Interaction p value, p = 0.008
Hip effusion
  Presence*10%18%0.0720%0.09
  Effusion CSA**, mean (SD)1.05 (0.79)1.16 (0.96)0.311.30 (1.01)0.02
Presence of radiological hip OA28%30%0.9440%0.002
  Men22%50%0.001
  Women27%27%0.97
  Interaction p value, p = 0.007
  • Significant data are in bold face. Results of t tests (continuous variables) and chi-squared tests (categorical variables), with standard errors of means calculated with clustering of observations on subjects at phase 2 and phase 3 taken into account. Two-way ANOVA test was used for estimating sex interactions.

  • Pain score calculated using Western Ontario and McMaster Universities Osteoarthritis index.

  • Presence of hip pain defined as grade 0 = no hip pain and grade 1 = pain score > 0.

  • § For subjects with hip pain score > 0.

  • * Presence of hip effusion dichotomized as grade 0 = no effusion or/and effusion CSA ≤ 2.0 cm2, and grade 1 = effusion ≥ 2.0 cm2.

  • ** Mean effusion and SD obtained using t test including only subjects with effusion CSA > 0. BMI: body mass index; BML: bone marrow lesions; CSA: cross-sectional area; OA: osteoarthritis.